In 2005, the NCI created a series of steering committees tasked with coordinating cancer research throughout the U.S. The steering committee for head and neck cancer was formed in 2007.
At the NCI’s request, the Institute of Medicine (IOM) conducted a review of the Clinical Trials Cooperative Group Program. The IOM released its report in 2010 that included goals for the NCI, including improving the speed and efficiency of trials, incorporating innovative science and trial design, improving prioritization and selection of trials and better incentivizing for physicians and patients who participate.
To do this, the IOM recommended consolidating some research groups using pre-defined metrics to make those choices; downsizing disease-site committees; consolidating back-office operations; better coordinating and streamlining protocol development and increasing reimbursements in high-ranked trials.